Phenotype
|
Fish
|
Conditions
|
Figures
|
whole organism gamma-linolenic acid increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
hepatocyte mitochondrial chromosome increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 8
from Han et al., 2021
|
liver fabp10a expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 5
from Han et al., 2021
|
liver atg5 expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 5
from Han et al., 2021
|
whole organism phosphatidylethanolamine decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
whole organism phosphatidylcholine decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
liver map1lc3b expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 5
from Han et al., 2021
|
whole organism tetracosenoic acid decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
liver ulk1b expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
liver atg12 expression amount, ameliorated
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 5
from Han et al., 2021
|
liver white, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
liver hspa5 expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 8
from Han et al., 2021
|
hepatocyte mitochondrion increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 8
from Han et al., 2021
|
whole organism decreased weight, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 4
from Han et al., 2021
|
liver il6 expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 8
from Han et al., 2021
|
liver map1lc3b expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
liver atg12 expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
liver pnpla2 expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
hepatocyte mitochondrion increased size, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 8
from Han et al., 2021
|
whole organism oxygen metabolic process decreased magnitude, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
hepatocyte lipid droplet increased size, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 4
from Han et al., 2021
|
whole organism docosahexaenoic acid decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
liver lipea expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
liver abhd5a expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
liver lipea expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
liver tfeb expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 5
from Han et al., 2021
|
liver mgll expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
liver il6 expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 8
from Han et al., 2021
|
liver atg4a expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 5
from Han et al., 2021
|
whole organism triglyceride increased amount, exacerbated
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 4
from Han et al., 2021
|
liver pnpla2 expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 5
from Han et al., 2021
|
liver ssbp1 expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 8
from Han et al., 2021
|
liver ulk1b expression amount, ameliorated
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 5
from Han et al., 2021
|
liver atg4a expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
whole organism triglyceride increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1,
Fig. 4
from Han et al., 2021
|
liver vacuolated, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
liver il1b expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 8
from Han et al., 2021
|
liver fabp10a expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
whole organism protein decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
liver tnfa expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 8
from Han et al., 2021
|
whole organism lipid increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 4
from Han et al., 2021
|
whole organism hexadecenoic acid increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
whole organism decreased weight, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1,
Fig. 4
from Han et al., 2021
|
liver becn1 expression amount, ameliorated
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 5
from Han et al., 2021
|
liver hspa5 expression increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
chemical treatment by diet: 3-methyladenine
|
Fig. 8
from Han et al., 2021
|
liver lipeb expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
liver atg7 expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
liver becn1 expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
whole organism elaidic acid increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
liver vacuole increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
liver fatty, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
whole organism icosenoic acid decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|
liver plin2 expression decreased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 5
from Han et al., 2021
|
whole organism lipid increased amount, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1,
Fig. 4
from Han et al., 2021
|
swimming decreased linear velocity, abnormal
|
pnpla2ecn8/ecn8 (AB)
|
standard conditions
|
Fig. 1
from Han et al., 2021
|